Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Toshiyuki Aramaki"'
Autor:
Kanako Tsutsumi, Narumichi Iwamura, Katsumi Eguchi, Ayuko Takatani, Tomohiro Koga, Takeshi Araki, Toshiyuki Aramaki, Kaoru Terada, Yukitaka Ueki
Publikováno v:
Immunological Medicine, Pp 1-10 (2024)
Although rapidly progressive glomerulonephritis (RPGN) is the main renal phenotype of microscopic polyangiitis (MPA), we aim to clarify the clinical features of slowly progressive MPA. This retrospective observational study included 12 patients diagn
Externí odkaz:
https://doaj.org/article/7e13539731b34ae0890bae658da3a850
Autor:
Narumichi Iwamura, Katsumi Eguchi, Tomohiro Koga, Kanako Tsutsumi, Takeshi Araki, Toshiyuki Aramaki, Ayuko Takatani, Kaoru Terada, Yukitaka Ueki
Publikováno v:
Immunological Medicine, Vol 46, Iss 2, Pp 97-107 (2023)
AbstractA 61-year-old man with no previous record of autoimmune disease developed fever, polyarthralgia, purpura, and urticaria-like rash 2 weeks after the first dose of the Moderna mRNA-1273 vaccine, and symptoms deteriorated following the second do
Externí odkaz:
https://doaj.org/article/4afa2e38eacc445dab39df9d013bfe1a
Autor:
Ayuko Takatani, Naoki Iwamoto, Serina Koto, Toshiyuki Aramaki, Kaoru Terada, Yukitaka Ueki, Atsushi Kawakami, Katsumi Eguchi
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe SARS-CoV-2 mRNA vaccine has been reported to cause various adverse reactions, including the development or exacerbation of autoimmune diseases, but the adverse reactions and the effects of the vaccines on disease activity in patients wi
Externí odkaz:
https://doaj.org/article/ac25a98b97a247d4888ba8d3ea8a2630
Autor:
Tomoki Origuchi, Masataka Umeda, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Toshiaki Tsukada, Taiichiro Miyashita, Nozomi Iwanaga, Yoshiro Horai, Kazuhiko Arima, Toshiyuki Aramaki, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami
Publikováno v:
Immunological Medicine, Pp 1-7 (2022)
Remitting seronegative symmetrical synovitis with pitting edema syndrome (RS3PE), a rheumatic disease affecting the elderly, responds well to corticosteroids; however, our RS3PE patients' corticosteroid therapy is longer than expected. Elderly-onset
Externí odkaz:
https://doaj.org/article/43b0af4aa16646ff9cd72e591e7bdfc2
Autor:
Naoki Iwamoto, Shuntaro Sato, Shota Kurushima, Toru Michitsuji, Shinya Nishihata, Momoko Okamoto, Yoshika Tsuji, Yushiro Endo, Toshimasa Shimizu, Remi Sumiyoshi, Takahisa Suzuki, Akitomo Okada, Tomohiro Koga, Shin-ya Kawashiri, Keita Fujikawa, Takashi Igawa, Toshiyuki Aramaki, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Akinari Mizokami, Tomoki Origuchi, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Objective To compare the efficacy and safety of tofacitinib and baricitinib in patients with RA in a real-world setting. Methods A total of 242 patients with RA who were treated with tofacitinib (n = 161) or baricitinib (n = 81) were enrolle
Externí odkaz:
https://doaj.org/article/1c8e820079284bae987b8836e8da78f7
Autor:
Shin-ya Kawashiri, Yushiro Endo, Ayako Nishino, Momoko Okamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Toshiyuki Aramaki, Yukitaka Ueki, Tamami Yoshitama, Nobutaka Eiraku, Naoki Matsuoka, Akitomo Okada, Keita Fujikawa, Hiroaki Hamada, Shuji Nagano, Yoshifumi Tada, Atsushi Kawakami
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background To evaluate the effect of treatment on serum bone biomarkers and explore whether serum bone biomarkers are associated with therapeutic response in rheumatoid arthritis (RA) patients treated with abatacept. Methods We enrolled 59 R
Externí odkaz:
https://doaj.org/article/b8e31628dec64b3a98a9239993ef96f6
Autor:
Naoki Iwamoto, Takeshi Araki, Ayaka Umetsu, Ayuko Takatani, Toshiyuki Aramaki, Kunihiro Ichinose, Kaoru Terada, Naoyuki Hirakata, Yukitaka Ueki, Atsushi Kawakami, Katsumi Eguchi
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveWe evaluated changes of HTLV-1 proviral loads (PVLs) during treatment for rheumatoid arthritis (RA) and investigated whether these changes affect the clinical course in HTLV-1-positive RA patients.MethodsA total of 41 HTLV-1-positive RA pati
Externí odkaz:
https://doaj.org/article/6785cf40f29c4bbe9fbef3414b758575
Autor:
Yuya Fujita, Shoichi Fukui, Masataka Umeda, Sosuke Tsuji, Naoki Iwamoto, Yoshikazu Nakashima, Yoshiro Horai, Takahisa Suzuki, Akitomo Okada, Toshiyuki Aramaki, Yukitaka Ueki, Akinari Mizokami, Tomoki Origuchi, Hiroshi Watanabe, Kiyoshi Migita, Atsushi Kawakami
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundA proportion of patients with immunogloblin G (IgG) 4-related disease (IgG4-RD) have hypocomplementemia. We aimed to identify characteristics of such patients.MethodsWe analyzed the demographic and clinical data and complement levels of 85
Externí odkaz:
https://doaj.org/article/43035859663a442e888566804437ac6f
Autor:
Shin-ya Kawashiri, Keita Fujikawa, Ayako Nishino, Akitomo Okada, Toshiyuki Aramaki, Toshimasa Shimizu, Masataka Umeda, Shoichi Fukui, Takahisa Suzuki, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Akinari Mizokami, Hideki Nakamura, Tomoki Origuchi, Yukitaka Ueki, Kiyoshi Aoyagi, Takahiro Maeda, Atsushi Kawakami
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-8 (2017)
Abstract Background In the present study, we explored the risk factors for relapse after discontinuation of biologic disease-modifying antirheumatic drug (bDMARD) therapy in patients with rheumatoid arthritis (RA) whose ultrasound power Doppler (PD)
Externí odkaz:
https://doaj.org/article/a6504019b3e14c079b5f56e2f023336a
Autor:
Naoki Iwamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Shoichi Fukui, Masataka Umeda, Ayako Nishino, Yoshiro Horai, Tomohiro Koga, Shin-Ya Kawashiri, Toshiyuki Aramaki, Kunihiro Ichinose, Yasuko Hirai, Mami Tamai, Hideki Nakamura, Kaoru Terada, Tomoki Origuchi, Katsumi Eguchi, Yukitaka Ueki, Atsushi Kawakami
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177057 (2017)
We evaluated the efficacy and safety of tofacitinib in patients with rheumatoid arthritis (RA) in a real-world setting.Seventy consecutive patients, for whom tofacitinib was initiated between November 2013 and May 2016, were enrolled. All patients fu
Externí odkaz:
https://doaj.org/article/a3f3e139d957491abe032249d0cc67ba